Markets:

Overview

News

Currencies

International

Treasuries

DENTSPLY SIRONA Inc. - Common Stock (NQ:XRAY)

10.40 +0.14 (+1.41%)

Streaming Delayed Price Updated: 11:19 AM EDT, Jun 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DENTSPLY SIRONA Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

3 Unprofitable Stocks That Fall Short

Today 0:35 EDT

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...

Via StockStory

1 Cash-Producing Stock with Exciting Potential and 2 We Avoid

June 05, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...

Via StockStory

Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

May 13, 2026

What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi...

Via StockStory

Topics Economy

The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q1 Earnings Call

May 12, 2026

Dentsply Sirona’s first quarter results reflected a company in the midst of operational transformation, with revenue holding steady year over year but outper...

Via StockStory

Topics Earnings World Trade

Dentsply Sirona (NASDAQ:XRAY) Shares Rally 5% After Mixed Q1 Results Beat Revenue Estimates ↗

May 05, 2026

Via Chartmill

DENTSPLY SIRONA INC (NASDAQ:XRAY) Q4 2025 Earnings: Revenue Beat Overshadows EPS Miss and Cautious 2026 Outlook ↗

February 26, 2026

Via Chartmill

Dentsply Sirona (XRAY) Q1 2026 Earnings Transcript ↗

May 06, 2026

Dentsply Sirona (XRAY) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics World Trade

XRAY Q1 Deep Dive: Revenue Flat as Dentsply Sirona Advances Restructuring and Product Initiatives

May 06, 2026

Dental products company Dentsply Sirona (NASDAQ:XRAY) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales were flat year on year...

Via StockStory

Dentsply Sirona (NASDAQ:XRAY) Beats Q1 CY2026 Sales Expectations

May 05, 2026

Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q1 CY2026, but sales were flat year on year at $880 million. ...

Via StockStory

Dentsply Sirona (XRAY) Reports Q1: Everything You Need To Know Ahead Of Earnings

May 03, 2026

Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting results this Tuesday after the bell. Here’s what investors should know. Dentsply Siro...

Via StockStory

Dental Equipment & Technology Stocks Q4 Recap: Benchmarking Dentsply Sirona (NASDAQ:XRAY)

April 26, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how dental equipment ...

Via StockStory

Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know

April 17, 2026

What Happened? A number of stocks jumped in the afternoon session as the reopening of the Strait of Hormuz signaled a cooling of global logistics and energy ...

Via StockStory

Topics Economy

1 Small-Cap Stock with Competitive Advantages and 2 We Avoid

April 03, 2026

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

Via StockStory

3 Unprofitable Stocks with Questionable Fundamentals

March 30, 2026

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv...

Via StockStory

3 Reasons to Avoid XRAY and 1 Stock to Buy Instead

March 30, 2026

Although the S&P 500 is down 3.2% over the past six months, Dentsply Sirona’s stock price has fallen further to $11.47, losing shareholders 9.6% of their cap...

Via StockStory

Topics Stocks

1 Healthcare Stock Worth Investigating and 2 That Underwhelm

March 27, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...

Via StockStory

What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year ↗

March 20, 2026

This medical technology firm delivers integrated blood management solutions to healthcare providers and plasma centers worldwide.

Via The Motley Fool

Topics Regulatory Compliance

Is Dentsply Sirona Stock a Buy After a Company Director Purchased 15,000 Shares? ↗

March 13, 2026

This global dental technology firm, with strong recurring revenues, reported a notable insider buy following a year of share price declines.

Via The Motley Fool

Topics Regulatory Compliance

3 Cash-Producing Stocks Walking a Fine Line

March 12, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

Topics Economy

3 Healthcare Stocks Paying the Highest Dividends of 2026 ↗

March 10, 2026

A handful of the industry's income-generating gems are hiding in plain sight.

Via The Motley Fool

3 Stocks Under $50 Walking a Fine Line

March 09, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

Envista, Baxter, Artivion, Dentsply Sirona, and Cigna Stocks Trade Down, What You Need To Know

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Via StockStory

Topics Economy

Why Are Dentsply Sirona (XRAY) Shares Soaring Today

February 27, 2026

Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) jumped 13.4% in the afternoon session after the company reported mixed fourth-quarter results, with investors seemingly focusing on a...

Via StockStory

Topics Earnings

DENTSPLY SIRONA (XRAY) Q4 2025 Earnings Transcript ↗

February 26, 2026

DENTSPLY SIRONA (XRAY) Q4 2025 Earnings Transcript

Via The Motley Fool

Topics World Trade

Dentsply Sirona’s (NASDAQ:XRAY) Q4 CY2025 Sales Top Estimates, Stock Soars

February 26, 2026

Dental products company Dentsply Sirona (NASDAQ:XRAY) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.2% year on year to $961 million. On the other hand, the company’s full-year...

Via StockStory

Dentsply Sirona Earnings: What To Look For From XRAY

February 25, 2026

Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting earnings tomorrow after the bell. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

Gold shatters $5,000: A new era for global finance as 'Sell America' trade takes hold

February 23, 2026

NEW YORK — In a move that has sent shockwaves through global financial centers, gold prices officially breached the historic $5,000 per ounce mark during early trading on February 23, 2026. The surge...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q3 Earnings?

January 28, 2026

What a brutal six months it’s been for Dentsply Sirona. The stock has dropped 23.6% and now trades at $12.31, rattling many shareholders. This was partly due to its softer quarterly results and may...

Via StockStory

1 Small-Cap Stock with Competitive Advantages and 2 Facing Challenges

January 26, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

Dentsply Sirona (XRAY) Stock Is Up, What You Need To Know

January 21, 2026

Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) jumped 3.8% in the afternoon session after Mizuho analyst Steven Valiquette raised the price target on the stock.

Via StockStory

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.